Factor IXa specific antibodies displaying factor VIIIa like activity

Details for Australian Patent Application No. 2004271706 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Scheiflinger, Friedrich; Kerschbaumer, Randolf

Agent Cullens

Pub. Number AU-B-2004271706

PCT Pub. Number WO2005/025615

Priority 10/661,366 12.09.03 US

Filing date 7 September 2004

Wipo publication date 24 March 2005

Acceptance publication date 2 September 2010

International Classifications

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025615 Priority application(s): WO2005/025615

2 September 2010 Application Accepted

  Published as AU-B-2004271706

6 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271715-6-halogeno-(1,2,4)triazolo(1,5-a)pyrimid ines for combating animal pests

2004271697-Combination of phenylcarboxamides with beta-adrenergic receptor blockers and use thereof for the treatment of atrial arrhythmias